Your browser doesn't support javascript.
loading
Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.
Lew, Meagan V; Ren, Yi; Lowder, Yen P; Siamakpour-Reihani, Sharareh; Ramalingam, Sendhilnathan; Romero, Kristi M; Thompson, Jillian C; Bohannon, Lauren M; McIntyre, Jackie; Tang, Helen; Van Opstal, Jolien; Johnson, Ernaya; Cohen, Harvey Jay; Bartlett, David B; Pastva, Amy M; Morey, Miriam; Hall, Katherine S; Smith, Patrick; Peters, Katherine B; Somers, Tamara J; Kelleher, Sarah; Smith, Sophia K; Wischmeyer, Paul E; Lin, Pao-Hwa; Wood, William A; Thorpe, Glynnis; Minor, Kerry; Wiggins, Kristi; Hennig, Therese; Helms, Tanya; Welch, Renee; Matthews, Brittany; Liu, JoAnn; Burleson, Jill; Aberant, Thomas; Engemann, Ashley K; Henshall, Bethany; Darby, Maurisa; Proch, Christina; Dellascio, Michelle; Pittman, Alyssa; Suminguit, Jacob; Choi, Taewoong; Gasparetto, Cristina; Long, Gwynn D; Lopez, Richard D; Sarantopoulos, Stefanie; Horwitz, Mitchell E; Chao, Nelson J; Sung, Anthony D.
Affiliation
  • Lew MV; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Ren Y; Duke Cancer Institute Biostatistics Shared Resources, Durham, North Carolina.
  • Lowder YP; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Siamakpour-Reihani S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Ramalingam S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Romero KM; Duke University School of Medicine, Durham, North Carolina.
  • Thompson JC; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Bohannon LM; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • McIntyre J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Tang H; Duke University School of Medicine, Durham, North Carolina.
  • Van Opstal J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina; Faculty of Medicine, KU Leuven, Leuven, Belgium.
  • Johnson E; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Cohen HJ; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina.
  • Bartlett DB; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; School of Biosciences and Medicine, University of Surrey, Surrey, United Kingdom.
  • Pastva AM; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Department of Orthopedic Surgery, Division of Physical Therapy, Duke University Medical Center, Durham, North Carolina.
  • Morey M; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Geriatric Research, Education and Clinical Center, Durham VA Healthcare System, Durham, North Carolina.
  • Hall KS; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina; Geriatric Research, Education and Clinical Center, Durham VA Healthcare System, Durham, North Carolina.
  • Smith P; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
  • Peters KB; Departments of Neurology and Neurosurgery, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
  • Somers TJ; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
  • Kelleher S; Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
  • Smith SK; School of Nursing, Duke University Medical Center, Durham, North Carolina.
  • Wischmeyer PE; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.
  • Lin PH; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina.
  • Wood WA; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Thorpe G; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Minor K; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Wiggins K; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Hennig T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Helms T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Welch R; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Matthews B; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Liu J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Burleson J; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Aberant T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Engemann AK; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Henshall B; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Darby M; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Proch C; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Dellascio M; Duke Health Department of Physical Therapy and Occupational Therapy, Durham, North Carolina.
  • Pittman A; Duke Health Department of Physical Therapy and Occupational Therapy, Durham, North Carolina.
  • Suminguit J; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Long GD; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina; Claude D. Pepper Older Americans Independence Center, Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, North Carolina. Electronic address: an
Transplant Cell Ther ; 28(8): 498.e1-498.e9, 2022 08.
Article in En | MEDLINE | ID: mdl-35595226
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2022 Type: Article